A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease

Christopher J. Ryerson, Tamera J. Corte, Jeffrey L. Myers, Simon L.F. Walsh, Sabina A. Guler

Source: Eur Respir J, 58 (6) 2100276; 10.1183/13993003.00276-2021
Journal Issue: December

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Christopher J. Ryerson, Tamera J. Corte, Jeffrey L. Myers, Simon L.F. Walsh, Sabina A. Guler. A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease. Eur Respir J, 58 (6) 2100276; 10.1183/13993003.00276-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The significance of addind rheumatological assessment to the multidisciplinary team in the diagnosis of interstitial lung disease.
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017

The multidisciplinary approach in the diagnosis of idiopathic pulmonary fibrosis: a patient case-based review
Source: Eur Respir Rev 2015; 24: 69-77
Year: 2015



The effectiveness of a multidisciplinary approach in the management of lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 495s
Year: 2005

Contemporary challenges for specialist nursing in interstitial lung disease
Source: Breathe, 14 (1) 36; 10.1183/20734735.014917
Year: 2018



Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need
Source: Breathe, 16 (3) 200066; 10.1183/20734735.0066-2020
Year: 2020



A pragmatic clinical classification for interstitial lung disease
Source: Annual Congress 2012 - Reclassification of idiopathic interstitial pneumonias
Year: 2012


Clinical management implications of histologic information provided by lung biopsy in the multidisciplinary evaluation of interstitial lung diseases.
Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology
Year: 2020




The characterisation of interstitial lung disease multidisciplinary team meetings: a global study
Source: ERJ Open Res, 5 (2) 00209-2018; 10.1183/23120541.00209-2018
Year: 2019



Early origins of lung disease: towards an interdisciplinary approach
Source: Eur Respir Rev, 29 (157) 200191; 10.1183/16000617.0191-2020
Year: 2020



Demonstration of diagnostic and prognostic benefits of an interstitial lung disease (ILD) multidisciplinary team meeting
Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease
Year: 2011


The internet-based network for the management of children with interstitial lung disease
Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease
Year: 2014




Diffuse lung disease in infancy: a working classification of the pediatric interstitial lung disease (pILD) multidisciplinary cooperative group
Source: Eur Respir J 2005; 26: Suppl. 49, 500s
Year: 2005

Global characterisation of routine care interstitial lung disease diagnostic practice
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017


Evidence-based consensus recommendations for the identification and management of interstitial lung disease in systemic sclerosis
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019

The collaborative approach to COPD management in primary care
Source: Eur Respir J 2004; 24: Suppl. 48, 84s
Year: 2004

Clinical management of the idiopathic interstitial pneumonias: an example of an integrated approach to interstitial lung diseases
Source: Annual Congress 2006 - PG8 - Interstitial lung diseases: idiopathic interstitial pneumonias
Year: 2006


Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 48-56
Year: 2012



The future of treatment for interstitial lung diseases: the patient’s and physician’s perspective
Source: International Congress 2019 – Rare lung diseases
Year: 2019


Multidisciplinary evaluation of interstitial lung diseases: current insights
Source: Eur Respir Rev, 26 (144) 170002; 10.1183/16000617.0002-2017
Year: 2017



Diffuse parenchymal lung disease: a practical overview Is a lung biopsy necessary for management?
Source: Breathe 2008; 4: 233-239
Year: 2008